Carlsmed's sales jumped 65% last quarter to $21.6 million, and they expect $78-$80 million this year.

Nov 10, 2026, 5:28 PM ETResultsRead the original at Benzinga

Good for CARL

Carlsmed grew Q3 sales 65%, raised its full-year sales forecast, and improved gross margin. Its adjusted loss remained $7.3 million, but growth and lower costs point to better prospects.

CARL · Carlsmed

AI read · Good for CARL

The AI's read

More surgeons are using Carlsmed’s system, and procedure volume rose 76% from a year earlier. Lower manufacturing costs also helped gross margin grow by 1.4 percentage points. The company’s adjusted loss was still $7.3 million, but it narrowed from $8.2 million. Sales growth and lower costs support a positive reading despite the continuing loss.

Get alerts for CARL

Follow Carlsmed (CARL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CARL

Free on the App Store and Google Play, or on the web.